Effects of PACAP and VIP on cyclic AMP formation in rat neuronal and astrocyte cultures under normoxic and hypoxic condition

Peptides

Volumn 28, Issue 9, 2007, Pages 1706-1712

  Nowak, Jerzy Z ^a,b   Jozwiak Bebenista, Marta ^a   Bednarek, Katarzyna ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b INSTITUTE OF MEDICAL BIOLOGY   (Poland)

Author keywords

Astrocytes; Cyclic AMP; Hypoxia; Neurons; Pituitary adenylate cyclase activating polypeptide (PACAP); Rat; Vasoactive intestinal peptide (VIP)

Indexed keywords

COBALT CHLORIDE; CYCLIC AMP; FORSKOLIN; GUANINE NUCLEOTIDE BINDING PROTEIN; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; OXYGEN; RECEPTOR PROTEIN; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN; CELL CULTURE; EMBRYO; FEMALE; GLIA CELL; HYPOXIA; NERVE CELL; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ASTROCYTES; CELL HYPOXIA; CELLS, CULTURED; CYCLIC AMP; DOSE-RESPONSE RELATIONSHIP, DRUG; FORSKOLIN; NEUROGLIA; NEURONS; OXYGEN; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RATS; VASOACTIVE INTESTINAL PEPTIDE;

RATTUS;

EID: 34548404227     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2007.04.007     Document Type: Article

References (52)

1. Arimura A. Perspectives on pituitary adenylate cyclase activating polypeptide (PACAP) in the neuroendocrine, endocrine, and nervous systems. Jpn J Physiol 48 (1998) 301-331
2. Ashur-Fabian O., Giladi E., Brenneman D.E., and Gozes I. Identification of VIP/PACAP receptors on rat astrocytes using antisense oligodeoxynucleotides. J Mol Neurosci 9 (1997) 211-222
3. Badr G.A., Zhang J.Z., Tang J., Kern T.S., and Ismail-Beigi F. Glut1 and Glut3 expression, but not capillary density, is increased by cobalt chloride in rat cerebrum and retina. Brain Res Mol Brain Res 64 (1999) 24-33
4. Brewer G.J. Serum-free B27/neurobasal medium supports differentiated growth of neurons from the striatum, substantia nigra, septum, cerebral cortex, cerebellum and dendate gyrus. J Neurosci Res 42 (1995) 674-683
5. Dejda A., Gendek-Kubiak H., and Nowak J.Z. Effect of different forms of vasoactive intestinal peptide on cAMP formation in the mammalian cerebral cortex. Pol J Pharmacol 56 (2004) 421-425
6. Dejda A., and Nowak J.Z. PACAP, VIP and PHI: effects on AC-, PLC-, and PLD-driven signaling systems in the primary glial cell cultures. Ann NY Acad Sci 1070 (2006) 220-225
7. Dejda A., Sokolowska P., and Nowak J.Z. Neuroprotective potential of three neuropeptides PACAP, VIP and PHI. Pharmacol Rep 57 (2005) 307-320
8. Goldberg M.A., Dunning S.P., and Bunn H.F. Regulation of the erythropoietin gene: evidence that the oxygen sensor is a hem protein. Science 242 (1988) 1412-1415
9. 1 receptor. J Neuroimmunol 158 (2005) 94-105
10. Gozes I., and Brenneman D.E. VIP: molecular biology and neurobiological function. Mol Neurobiol 3 (1989) 201-236
11. Gozes I., McCune S.K., Jacobson L., Warren D., Moody T.W., Fridkin M., et al. An antagonist to vasoactive intestinal peptide affects cellular functions in the central nervous system. J Pharmacol Exp Ther 257 (1991) 959-966
12. Grasselli F., Basini G., Bussolatti S., and Bianco F. Cobalt chloride, a hypoxia-mimicking agent, modulates redox status and functional parameters of cultured swine granulose cells. Reprod Fertil Dev 17 (2005) 715-720
13. Grimaldi M., and Cavallaro S. Functional and molecular diversity of PACAP/VIP receptors in cortical neurons and type I astrocytes. Eur J Neurosci 11 (1999) 2767-2772
14. Halonen S.K., Chiu F.C., and Weiss L.M. Effect of cytokines on growth of toxoplasma gondii in murine astrocytes. Infect Immun 66 (1998) 4989-4993
15. Harmar A.J., Arimura A., Gozes I., Journot L., Laburthe M., Pisegna J.R., et al. International Union Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. Pharmacol Rev 50 (1998) 265-270
16. Hertz L., Juurlink B.H.J., and Szuchet S. Cell cultures. In: Lajtha A. (Ed). Handbook of neurochemistry vol. 8 (1985), Plenum Press, New York 603-661
17. Ijichi A., Sakuma S., and Tofilon P.J. Hypoxia-induced vascular endothelial growth factor expression in normal rat astrocyte cultures. Glia 14 (1995) 87-93
18. Jaworski D.M. Expression of pituitary adenylate cyclase-activating polypeptide (PACAP) and the PACAP-selective receptor in cultured rat astrocytes, human brain tumors, and in response to acute intracranial injury. Cell Tissue Res 300 (2000) 219-230
19. Jozwiak-Bebenista M, Dejda A, Nowak JZ. Effects of PACAP, VIP and related peptides on cyclic AMP formation in rat neuronal and astrocyte cultures and cerebral cortical slices. Pharmacol Rep, in press.
20. Kotake-Nara E., Takizawa S., Quan J., Wang H., and Saida K. Cobalt chloride induces neurite outgrowth in rat pheochromocytoma PC-12 cells through regulation of endothelin-2/vasoactive intestinal contractor. J Neurosci Res 81 (2005) 563-571
21. Laburthe M., and Couvineau A. Molecular pharmacology and structure of VPAC receptors for VIP and PACAP. Regul Pept 108 (2002) 165-173
22. Li M., David C., Kikuta T., Somogyvari-Vigh A., and Arimura A. Signaling cascades involved in neuroprotection by subpicomolar pituitary adenylate cyclase-activating polypeptide 38. J Mol Neurosci 27 (2005) 91-106
23. Lutz E.M., Ronaldson E., Shaw P., Johnson M.S., Holland P.J., and Mitchell R. Characterization of novel splice variants of the PAC1 receptor in human neuroblastoma cells: consequences for signaling by VIP and PACAP. Mol Cell Neurosci 31 (2006) 193-209
24. Masmoudi O., Gandolfo P., Leprince J., Vaudry D., Fournier A., Patte-Mensah C., et al. Pituitary adenylate cyclase-activating polypeptide (PACAP) stimulates endozepine release from cultured rat astrocytes via PKA-dependent mechanism. FASEB J 17 (2003) 17-21
25. Namiecinska M., Wiktorowska-Owczarek A., Loboda A., Dulak J., and Nowak J.Z. Cyclic AMP generating system in human microvascular endothelium is highly responsie to adrenaline. Pharmacol Rep 58 (2006) 884-889
26. Nowak J.Z., and Kuba K. Vasoactive intestinal peptide-stimulated adenosine 3′,5′-cyclic monophosphate formation in cerebral cortex and hypothalamus of chick and rat: comparison of the chicken and mammalian peptide. Neurosci Lett 297 (2001) 93-96
27. Nowak J.Z., and Kuba K. Pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide-stimulated cyclic AMP synthesis in rat cerebral cortical slices: interaction with noradrenaline, adrenaline, and forskolin. J Mol Neurosci 18 (2002) 47-52
28. Nowak J.Z., Kuba K., and Zawilska J.B. Stimulatory effect of pituitary adenylate cyclase-activating polypeptide (PACAP) on cyclic AMP formation in the hypothalamus and cerebral corex of four avians and rat. Pol J Pharmacol 51 (1999) 87-91
29. Nowak J.Z., Kuba K., and Zawilska J.B. Effects of neuropeptides of the secretin/VIP/PACAP family on cyclic AMP formation in the chik hypothalamus and cerebral cortex. Pol J Pharmacol 52 (2000) 467-471
30. Nowak J.Z., Kuba K., and Zawilska J.B. Effecs of pituitary adenylate cyclase-activating polypeptide (PACAP) on cyclic AMP formation in the duck and goose brain. Acta Neurobiol Exp 60 (2000) 209-214
31. Nowak J.Z., and Zawilska J.B. PACAP in avians: origin, occurrence, and receptors-pharmacological and functional considerations. Curr Pharm Des 9 (2003) 467-481
32. Nussdorfer G.G., and Malendowwicz L.K. Role of VIP, PACAP, and related peptides in the regulation of the hypothalamo-pituitary-adrenal axis. Peptides 19 (1998) 1443-1467
33. Pilzer I., and Gozes I. VIP provides cellular protection through a specific splice variant of the PACAP receptor: a new neuroprotection target. Peptides 27 (2006) 2867-2876
34. 2 receptors mediate vasoactive intestinal peptide-induced neuroprotection against neonatal excitotoxic brain lesions in mice. J Pharmacol Exp Ther 314 (2005) 745-752
35. Ravni A., Bourgault S., Lebon A., Chan P., Galas L., Fournier A., et al. The neurotrophic effects of PACAP in PC12 cells: control by multiple transduction pathways. J Neurochem 98 (2006) 321-329
36. Salomon Y., Londos C., and Rodbell M. A highly sensitive adenyalte cyclase assay. Analyt Biochem 58 (1974) 541-548
37. Seamon K.B., and Daly J.W. Forskolin: its biological and chemical properties. Adv Cycl Nucleotide Protein Phosphoryl Res 20 (1986) 1-150
38. Sedkowska P., Niewiadomski P., Zawilska J.B., and Nowak J.Z. PACAP and VIP peptides: localization, receptors, and physiological function. Post Biol Kom 30 (2003) 525-547 [n Polish]
39. Sherwood N.M., Krueckl S.L., and McRory J.E. The origin and function of the pituitary adenylate cyclase-activating polypeptide (PACAP)/glucagon superfamily. Endocr Rev 21 (2000) 619-670
40. Shimizu H., Daly J.W., and Creveling C.R. A radioisotopic method for measuring the formation of adenosine 3′,5′-cyclic monophosphate in incubated slices of brain. J Neurochem 16 (1969) 1609-1619
41. Shintani N., Suetake S., Hashimoto H., Koga K., Kasai A., Kawaguchi C., et al. Neuroprotective action of endogenous PACAP in cultured rat cortical neurons. Regul Pept 126 (2005) 123-128
42. Somogyvari-Vigh A., and Reglodi D. Pituitary adenylate cyclase activating polypeptide: a potential neuroprotective peptide. Curr Pharm Des 10 (2004) 2861-2889
43. Suk K., Park J.H., and Lee W.H. Neuropeptide PACAP inhibits hypoxic activation of brain microglia: a protective mechanism against microglial neurotoxicity in ischemia. Brain Res 1026 (2004) 151-156
44. Tamas A., Gabriel R., Racz B., Denes V., Kiss P., Lubics A., et al. Effects of pituitary adenylate cyclase activating polypeptide in retinal degeneration induced by monosodium-glutamate. Neurosci Lett 372 (2004) 110-113
45. Tatsuno I., Gottschall P.E., and Arimura A. Specific binding sites for pituitary adenylate cyclase activating polypeptide (PACAP) in rat cultured astrocytes. Molecular identification and interaction with vasoactive intestinal peptide (VIP). Peptides 12 (1991) 617-621
46. Vaudry D., Gonzalez B.J., Basille M., Yon L., Fournier A., and Vaudry H. Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions. Pharmacol Rev 52 (2000) 269-324
47. Wang G.L., and Semenza G.L. Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: implications for models of hypoxia signal transduction. Blood 82 (1993) 3610-3615
48. 2 in rat neuronal PC12 cells. Nucleic Acids Res 28 (2000) 2135-2140
49. Yang S.J., Pyen J., Lee I., Lee H., Kim Y., and Kim T. Cobalt chloride-induced apoptosis and extracellular signal-regulated protein kinase 1/2 activation in rat C6 glioma cells. J Biochem Mol Biol 37 (2004) 480-486
50. Zawilska J.B., Niewiadomski P., and Nowak J.Z. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating polypeptide receptors in chick cerebral cortex. J Mol Neurosci 20 (2003) 153-161
51. 125I]-VIP binding and effects on cyclic AMP synthesis. Gen Comp Endocrinol 137 (2004) 187-195
52. Zawilska J.B., Niewiadomski P., and Nowak J.Z. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in the goose cerebral cortex. Pol J Pharmacol 56 (2004) 203-211